Zhiqiang Shu
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
8
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Zhiqiang Shu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Initiates: Buy | $26 | $30.00 | -13.33% | 1 | Mar 23, 2023 | |
| KRON Kronos Bio | Initiates: Buy | $12 | $0.95 | +1,163.16% | 1 | Sep 14, 2022 | |
| BPMC Blueprint Medicines | Initiates: Buy | $90 | $91.88 | -2.05% | 1 | Sep 14, 2022 | |
| STRO Sutro Biopharma | Initiates: Buy | $30 | $3.69 | +713.01% | 1 | Nov 17, 2021 | |
| SNSE Sensei Biotherapeutics | Downgrades: Hold | $12 | $0.52 | +2,212.14% | 1 | Jul 1, 2021 | |
| NRIX Nurix Therapeutics | Initiates: Buy | n/a | $25.04 | - | 1 | Apr 14, 2021 | |
| STTK Shattuck Labs | Initiates: Buy | $47 | $1.16 | +3,951.72% | 1 | Apr 14, 2021 | |
| RPTX Repare Therapeutics | Initiates: Buy | $51 | $3.58 | +1,324.58% | 1 | Mar 1, 2021 |
IDEAYA Biosciences
Mar 23, 2023
Initiates: Buy
Price Target: $26
Current: $30.00
Upside: -13.33%
Kronos Bio
Sep 14, 2022
Initiates: Buy
Price Target: $12
Current: $0.95
Upside: +1,163.16%
Blueprint Medicines
Sep 14, 2022
Initiates: Buy
Price Target: $90
Current: $91.88
Upside: -2.05%
Sutro Biopharma
Nov 17, 2021
Initiates: Buy
Price Target: $30
Current: $3.69
Upside: +713.01%
Sensei Biotherapeutics
Jul 1, 2021
Downgrades: Hold
Price Target: $12
Current: $0.52
Upside: +2,212.14%
Nurix Therapeutics
Apr 14, 2021
Initiates: Buy
Price Target: n/a
Current: $25.04
Upside: -
Shattuck Labs
Apr 14, 2021
Initiates: Buy
Price Target: $47
Current: $1.16
Upside: +3,951.72%
Repare Therapeutics
Mar 1, 2021
Initiates: Buy
Price Target: $51
Current: $3.58
Upside: +1,324.58%